Explore the Potential with AI-Driven Innovation
The specialised, focused library is developed on demand with the most recent virtual screening and parameter assessment technology, guided by the Receptor.AI drug discovery platform. This approach exceeds the capabilities of traditional methods and offers compounds with higher activity, selectivity, and safety.
Our selection of compounds is from a large virtual library of over 60 billion molecules. The production and distribution of these compounds are managed by our partner Reaxense.
The library includes a list of the most effective modulators, each annotated with 38 ADME-Tox and 32 physicochemical and drug-likeness parameters. Furthermore, each compound is shown with its optimal docking poses, affinity scores, and activity scores, offering a detailed summary.
We employ our advanced, specialised process to create targeted libraries for enzymes.
Fig. 1. The sreening workflow of Receptor.AI
It includes in-depth molecular simulations of both the catalytic and allosteric binding pockets, with ensemble virtual screening focusing on their conformational flexibility. For modulators, the process includes considering the structural shifts due to reaction intermediates to boost activity and selectivity.
Our library distinguishes itself through several key aspects:
partner
Reaxense
upacc
O43865
UPID:
SAHH2_HUMAN
Alternative names:
DC-expressed AHCY-like molecule; IP(3)Rs binding protein released with IP(3); Putative adenosylhomocysteinase 2; S-adenosyl-L-homocysteine hydrolase 2
Alternative UPACC:
O43865; B4E168; Q2TAJ6; Q502W8; Q5VSM0; Q6P171; Q96PK4; Q9UG84
Background:
S-adenosylhomocysteine hydrolase-like protein 1, also known as AHCYL1, plays a pivotal role in cellular regulation, impacting processes such as epithelial HCO3(-) and fluid secretion, mRNA processing, and DNA replication. It modulates ITPR1 sensitivity, facilitates ER to mitochondria Ca(2+) transfer, and under stress, promotes apoptosis. AHCYL1's interaction with various transporters and enzymes underscores its importance in cellular homeostasis and signaling.
Therapeutic significance:
Understanding the role of S-adenosylhomocysteine hydrolase-like protein 1 could open doors to potential therapeutic strategies. Its involvement in critical cellular functions and stress response mechanisms highlights its potential as a target for therapeutic intervention in diseases where these processes are dysregulated.